Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-08-13

Clinical Trial Update: Preventing Recurrent Gestational Diabetes With Metformin [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating metformin to prevent recurrent gestational diabetes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • metformin (metformin)

Snippet

Sponsor: Imperial College London | Conditions: Gestational Diabetes Mellitus | Phase 4 | Status: UNKNOWN